SCHEMBL29808208

SCHEMBL29808208

Cc1ccnc(SCc2nnc(-c3ccccc3)o2)n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 10/20 0.54
▸ SMN1; SMN2 Q16637 6/20 0.54
▸ LMNA P02545 5/20 0.54
▸ KDM4E B2RXH2 2/20 0.54
▸ MITF O75030 1/20 0.54
▸ ALDH1A1 P00352 6/20 0.51
▸ TSHR P16473 3/20 0.51
▸ GAA P10253 2/20 0.51
▸ HTT P42858 2/20 0.50
▸ POLB P06746 2/20 0.49
▸ NPC1 O15118 3/20 0.48
▸ RAB9A P51151 3/20 0.48
▸ NPSR1 Q6W5P4 2/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ USP2 O75604 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ CYP3A4 P08684 1/20 0.46
▸ CYP2C9 P11712 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ PPARG P37231 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31494405 0.80 HSD17B10 (0.58) HPGDSMN1; SMN2LMNAKDM4EMITF
SCHEMBL29808087 0.80 KDM4E (0.49) HPGDSMN1; SMN2KDM4EPOLBNPC1
SCHEMBL29808182 0.77 NOTUM (0.48) HPGDSMN1; SMN2LMNAKDM4EALDH1A1
SCHEMBL29807808 0.77 TSHR (0.61) SMN1; SMN2LMNAALDH1A1TSHRHTT
SCHEMBL29808180 0.75 SMN1; SMN2 (0.57) HPGDSMN1; SMN2LMNAKDM4EALDH1A1
SCHEMBL5695138 0.74 HSD17B10 (0.65) SMN1; SMN2LMNAKDM4EALDH1A1POLB
SCHEMBL29808127 0.74 MAPT (0.58) HPGDSMN1; SMN2LMNAKDM4EALDH1A1
SCHEMBL31494390 0.73 MAPT (0.51) HPGDSMN1; SMN2LMNAKDM4EALDH1A1
SCHEMBL29808327 0.72 ALDH1A1 (0.52) HPGDSMN1; SMN2LMNAKDM4EALDH1A1
SCHEMBL29808335 0.72 SMN1; SMN2 (0.58) HPGDSMN1; SMN2LMNAKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220274968-A1 Oxazole And Oxadiazole Derivatives Useful As Agonists Of Free Fatty Acid Receptor 1 GBIOTECH S.À.R.L. (CH) 2022-09-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220274968-A1 Oxazole And Oxadiazole Derivatives Useful As Agonists Of Free Fatty Acid Receptor 1 FFAR2, FFAR1, FFAR3 HPGD 1443/4885SMN1; SMN2 3576/4885LMNA 4289/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback